RETHINK
LEARNING

Managing T2DM is multifaceted, requires individualised therapy and overlaps with multiple other chronic conditions, which all must be considered when applying a combination of patient-centred pharmacological and non-pharmacological interventions. This clinical audit systematically reviews aspects of a GP's clinical performance against defined best-practice guidelines for T2DM.

This 4-hour accredited education module focuses on the assessment and management of diabetes-related comorbidities and complications in patients with type 2 diabetes mellitus (T2DM). Throughout the course we look at the interplay between comorbidities and complications and their impact on treatment strategies, and vice versa. The first activity emphasises the need (and rationale) for comorbidity screening in both newly diagnosed and treatment-experienced patients with...

This activity is a planned medical education/clinical audit that systematically reviews aspects of a GP's clinical performance against defined best-practice guidelines. It can be undertaken by an individual GP or a small group.

This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs.

This activity focuses on the complex needs of patients presenting with chronic non-cancer pain (CNCP).

Head and Neck Cancer refers to the cancers of the head and neck region, particularly to mucosal cancers affecting the oral cavity, pharynx, sinonasal cavity, and larynx. The impacts of Head and Neck Cancer are far reaching. Treatment can take away basic abilities that we otherwise take for granted or result in facial disfigurement. Moreover, Head and Neck Cancer treatment is complex and can be debilitating, both physically and mentally, emphasising the importance of prevention.

This module is based on footage recorded from the Round Table discussion and focuses on the identification of patients with severe asthma that may not be optimally managed for various reasons and possible treatment options that can reduce symptoms, reduce oral corticosteroid burden, reduce the risk of exacerbations, and improve overall quality of life.

An interactive online activity designed to empower general practitioners (GPs) with communication skills that increase the effectiveness and level of confidence of their conversations with patients regarding vaccination.

This activity is based on a 2021 MCI Masterclass event and has been designed to increase your confidence in identifying patients with MCI and differentiating MCI from normal aging. It will look at the diagnostic and classification criteria for MCI and the rationale for referral for imaging and/or specialist consultation. It will also include some recommendations for the management of MCI, including the rationale for foods for special medical purposes.

This activity has been designed to increase your confidence in identifying and managing patients susceptible to experiencing emergency anaphylaxis reactions, including the prescribing of available adrenaline autoinjectors. It aims to highlight the differences between allergic and anaphylactic reactions, review the most current and updated guidelines regarding the indications and dosage of adrenaline autoinjectors and ensure best practice in anaphylaxis management in general practice.

An interactive online activity focusing on the identification and management of overactive bladder (OAB).

This activity has been designed to increase your confidence in identifying and managing heart failure (HF) in a general practice setting. It aims to improve the quality of life of patients who may be exhibiting mild to moderate symptoms despite already being treated with HF medication.

Each year, the National Vaccine Forum brings together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding vaccines in Australia.

Compare your clinical approach to your peers in an interactive e-learning module with expert commentary and practical tips by Sleep and Respiratory Specialist, A/Professor Jeremy Goldin.

This activity describes benign prostatic hyperplasia (BPH), its common symptoms, diagnosis, and reviews management options in patients who are not effectively managed on oral therapies. The emerging role of minimally invasive surgical options for the treatment of BPH is highlighted.

Each year, the National Vaccine Forum brings together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding vaccines in Australia.

This education focuses on the identification of patients with treatment-resistant mental health conditions suitable (and eligible) for treatment with cannabidiol (CBD) and CBD-dominant pharmaceutical cannabis.

A case study-based on-demand webinar which looks at providing a patient-centric, tailored approach to the optimal management of chronic obstructive pulmonary disease in general.practice.

In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies.

This on-demand webinar is based on panel discussion with three eminent healthcare professionals.

An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling.

Best practise management of patients with pancreatic exocrine insufficiency (PEI).

This year the Cardio-Respiratory Masterclass, chaired by Professor Garry Jennings, Interim CEO of National Heart Foundation, brought together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding the impact of respiratory illness on cardiovascular health in Australia. This year's discussion specifically revolved around influenza, COVID-19, and cardiovascular outcomes.

This activity has been designed to take 1 hour to complete and is suitable for 1 hour of Educational Activities in Category 1 in the RACP's MyCPD programme or Section 4 Self-guided Learning in the RANZCP CPD Program.

This activity is based on footage from a 2022 event with Adjunct Clinical Associate Professor Natasha Michael, where she focused on breakthrough cancer pain as a separate entity to cancer pain.

This activity has been designed to increase your confidence in identifying and managing patients susceptible to experiencing emergency anaphylaxis reactions, including the prescribing of available adrenaline autoinjectors. It aims to highlight the differences between mild/moderate reactions and anaphylaxis, review the most current and updated guidelines regarding the indications and dosage of adrenaline autoinjectors and ensure best practice in anaphylaxis management in general practice.

This activity provides an overview of spondyloarthropathy and reviews the efficacy, safety, and role of interleukin-17 inhibitors in patients with ankylosing spondylitis naive to, with inadequate response to, or with intolerance of, biologics.

In this activity, two of Australia's leading neurologists A/Prof Piero Perucca and A/Prof Doug Crompton meet to discuss the identification and mitigation of sudden unexpected death in epilepsy (SUDEP) risk in patients with ongoing/uncontrolled seizures, particularly those experiencing tonic-clonic seizures.

This activity will focus on the role of interleukin-17 (IL-17) inhibitors in the treatment of psoriatic arthritis (PsA) patients who showed an inadequate response to conventional disease-modifying antirheumatic drugs (cDMARDS), review the updated treatment guidelines regarding initiation of IL-17 inhibitors, and discuss the clinical evidence to support IL-17 inhibitors.

Hear from three of Australia's top rheumatologists A/Prof Östör, Dr Tellus and A/Prof Bird in this videocast-style learning activity.

This activity will focus on the management of existing patients diagnosed with RA who are showing incomplete response to conventional disease-modifying antirheumatic drugs (cDMARDS)

A case study-based activity focusing on patient selection for, and practical aspects of, tyrosine kinase inhibitors in RAI-R DTC.

An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on prescribing and counselling.

This on-demand webinar is based on panel discussion with three eminent healthcare professionals.

This activity is based on footage from a 2022 event with Adjunct Clinical Associate Professor Natasha Michael, where she focused on breakthrough cancer pain as a separate entity to cancer pain.

This activity has been designed to increase your confidence in identifying and managing patients susceptible to experiencing emergency anaphylaxis reactions, including the prescribing of available adrenaline autoinjectors. It aims to highlight the differences between mild/moderate reactions and anaphylaxis, review the most current and updated guidelines regarding the indications and dosage of adrenaline autoinjectors and ensure best practice in anaphylaxis management in general practice.

An interactive online activity designed to empower nurses with communication skills that increase the effectiveness and level of confidence of their conversations with patients regarding vaccination.

Each year, the National Vaccine Forum brings together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding vaccines in Australia.

This activity has been designed to increase your confidence in identifying and managing heart failure (HF) in a general practice setting. It aims to improve the quality of life of patients who may be exhibiting mild to moderate symptoms despite already being treated with HF medication.

This activity focuses on defining neuroendocrine tumour (NET) as a cancer, as well as on the signs, symptoms and classifications of NETs.

In this activity, Dr Barton Jennings, MBBS, FRACP, Specialist in Respiratory Medicine and Sleep Disorders, discusses the importance of spirometry testing in general practice and demonstrates how to interpret spirometry results using real patient case studies.

An overview of the development and approval processes of biosimilar medicines in Australia.

This module covers the pathophysiology of PEI, risk factors, signs and symptoms, complications, diagnosis, management strategies, such as treatment with pancreatic enzyme replacement therapy (PERT), including CREON^®.

Each year, the National Vaccine Forum brings together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding vaccines in Australia.

This activity has been designed to increase your confidence in identifying and managing patients susceptible to experiencing emergency anaphylaxis reactions, including the prescribing of available adrenaline autoinjectors. It aims to highlight the differences between mild/moderate reactions and anaphylaxis, review the most current and updated guidelines regarding the indications and dosage of adrenaline autoinjectors and ensure best practice in anaphylaxis management in general practice.

An interactive online activity designed to empower pharmacists with communication skills that increase the effectiveness and level of confidence of their conversations with customer regarding vaccination.

Each year, the National Vaccine Forum brings together Australia's primary healthcare professionals for a dynamic and engaging discussion on the current challenges and possibilities surrounding vaccines in Australia.

An overview of the development and approval processes of biosimilar medicines in Australia, with practical tips on dispensing and counselling.

This on-demand webinar is based on panel discussion with eminent healthcare professionals.